Tag: ABK Biomedical

ABK Medical

ABK Biomedical announces FDA 510(k) clearance of Easi-Vue embolic microspheres for...

ABK Biomedical has announced US Food and Drug Administration (FDA) 510(k) clearance of Easi-Vue embolic microspheres for the treatment of patients suffering from arteriovenous...

ABK Biomedical appoints Michael J Mangano as president and CEO

ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...